May 31, 2017 - By Winifred Garcia
Cliffs Natural Resources Inc. is a mining and natural resources company. The company has market cap of $1.81 billion. The Firm is a supplier of iron ore pellets to the North American steel industry from its mines and pellet plants located in Michigan and Minnesota. It has a 22.4 P/E ratio. The Company’s divisions include U.S.
Guyasuta Investment Advisors Inc increased Thermo Fisher Scientific (TMO) stake by 3.36% reported in 2016Q4 SEC filing. Guyasuta Investment Advisors Inc acquired 4,036 shares as Thermo Fisher Scientific (TMO)’s stock rose 8.13%. The Guyasuta Investment Advisors Inc holds 124,063 shares with $17.51 million value, up from 120,027 last quarter. Thermo Fisher Scientific now has $67.72B valuation. The stock rose 0.02% or $0.03 reaching $173.28 per share. About shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since May 31, 2016 and is uptrending. It has underperformed by 1.13% the S&P500.
Among 15 analysts covering Thermo Fisher Scientific (NYSE:TMO), 13 have Buy rating, 0 Sell and 2 Hold. Therefore 87% are positive. Thermo Fisher Scientific had 31 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Overweight” rating by JP Morgan on Thursday, September 22. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Hold” rating given on Friday, April 29 by Jefferies. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Buy” rating given on Tuesday, May 3 by Mizuho. Stifel Nicolaus maintained it with “Buy” rating and $158 target in Monday, January 11 report. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Buy” rating by Mizuho on Friday, May 27. As per Friday, September 9, the company rating was downgraded by Cleveland. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Americas Conviction Buy List” rating given on Tuesday, December 8 by Goldman Sachs. The company was maintained on Friday, April 28 by Leerink Swann. Argus Research initiated Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Tuesday, October 6. Argus Research has “Buy” rating and $145 target. The rating was maintained by Mizuho with “Buy” on Thursday, July 23.
Guyasuta Investment Advisors Inc decreased Express Scripts Hldg Co (NASDAQ:ESRX) stake by 6,175 shares to 4,308 valued at $296,000 in 2016Q4. It also reduced Ceco Environmental Corp (NASDAQ:CECE) stake by 25,000 shares and now owns 99,155 shares. Exxon Mobil Corp (NYSE:XOM) was reduced too.
Investors sentiment increased to 1.05 in Q4 2016. Its up 0.26, from 0.79 in 2016Q3. It improved, as 52 investors sold TMO shares while 371 reduced holdings. 116 funds opened positions while 329 raised stakes. 330.70 million shares or 0.57% less from 332.58 million shares in 2016Q3 were reported. 88,347 are owned by Hudson Bay Mgmt Limited Partnership. Princeton Alpha Lp holds 13,544 shares. Laffer Invs stated it has 16,990 shares. Cohen Capital Mngmt Inc stated it has 79,195 shares or 3.04% of all its holdings. Bessemer Group invested in 0.85% or 1.31M shares. Adams Diversified Equity Fund holds 1.27% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 145,400 shares. Nippon Life Ins invested in 0.06% or 20,312 shares. Hartford Fincl Incorporated invested in 64 shares. Trustmark Bank Trust Department holds 0.15% or 8,284 shares. Moreover, Waters Parkerson And Company Limited Company has 3.01% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). 19,825 were reported by Graybill Bartz Associates. Invest Prns Limited Oh Adv has 0.22% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 1,584 shares. Burt Wealth Advsr has 0.03% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Schafer Cullen Mngmt owns 0.08% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 40,130 shares. Atlanta Cap Mgmt L L C holds 896,952 shares.
Since March 6, 2017, it had 0 insider purchases, and 7 sales for $8.55 million activity. $1.46 million worth of Thermo Fisher Scientific Inc. (NYSE:TMO) was sold by WILVER PETER M on Wednesday, March 15. Another trade for 4,688 shares valued at $805,750 was sold by Shine Daniel P. Shares for $498,667 were sold by HOOGASIAN SETH H. 4,049 shares were sold by Loewald Thomas W, worth $642,617. CASPER MARC N had sold 20,000 shares worth $3.17 million. $396,775 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) shares were sold by Williamson Stephen.
Since January 1, 0001, it had 6 insider purchases, and 0 sales for $1.43 million activity.
About 113,817 shares traded. Cliffs Natural Resources Inc (CLF) has risen 122.26% since May 31, 2016 and is uptrending. It has outperformed by 105.56% the S&P500.
Analysts await Cliffs Natural Resources Inc (NYSE:CLF) to report earnings on July, 27. They expect $0.41 earnings per share, up 583.33% or $0.35 from last year’s $0.06 per share. CLF’s profit will be $122.66 million for 3.69 P/E if the $0.41 EPS becomes a reality. After $-0.11 actual earnings per share reported by Cliffs Natural Resources Inc for the previous quarter, Wall Street now forecasts -472.73% EPS growth.
Ratings analysis reveals 0 of Cliffs Natural Resources’s analysts are positive. Out of 2 Wall Street analysts rating Cliffs Natural Resources, 0 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. CLF was included in 2 notes of analysts from October 13, 2016. The firm earned “Equal-Weight” rating on Monday, November 14 by Morgan Stanley. The stock of Cliffs Natural Resources Inc (NYSE:CLF) earned “Mkt Perform” rating by FBR Capital on Thursday, October 13.
Gallagher Fiduciary Advisors Llc holds 4.71% of its portfolio in Cliffs Natural Resources Inc for 1.87 million shares. Bogle Investment Management L P De owns 1.32 million shares or 0.76% of their US portfolio. Moreover, Harvey Partners Llc has 0.53% invested in the company for 60,141 shares. The Florida-based Voloridge Investment Management Llc has invested 0.43% in the stock. L & S Advisors Inc, a California-based fund reported 187,596 shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.